Gain a US perspective on the latest technologies and novel biomarkers driving forward translational research and precision medicine

Featuring 40+ presentations, the event brings together over 300 attendees from leading pharma, biotech and academic organisations working in the biomarker industry across multiple therapeutic areas, allowing attendees to gain insights into the latest novel biomarker data and technologies.

Agenda at a Glance

Day One

Biomarkers in Drug Discovery & Translational Sciences

• Qualification of biomarkers for translational studies
• Efficacy and PK/PD biomarkers in drug development
• Case studies in biomarker discovery and validation

Biomarkers for Diagnostic Development

• Diagnostic development: Companion, Tissue & PoC
• Case studies in early detection and personalised medicine

Biomarkers for Clinical Development

• Implementing clinical biomarkers across: oncology, cardiometabolic and infectious
  disorders
• Transforming clinical development through biomarker driven clinical trial design

Day Two

New Biomarker Technologies & Data

• Imaging technologies, CNS imaging techniques and digital pathology
• Multiplexing technologies, flow cytometry and mass spectrometry
• Immunoassays and screening processes
  Genomic Markers in Precision Medicine &

Genomic Markers in Precision Medicine & Clinical Practice

• Translating genomic markers into the clinic
• The role of liquid biopsy in precision medicine